Table 2 Univariate and multivariate analyses for survival outcomes in study population

Histology

Non-SCC vs. SCC

2.200

1.075–4.505

0.031

2.647

1.253–5.590

0.011

2.403

0.747–7.732

0.142

2.186

0.663–7.215

0.199

2009 FIGO stage

IIA vs. IB

0.860

0.403–1.835

0.696

1.876

0.650–5.416

0.245

Para-aortic lymphadenectomy

Yes vs. No

1.090

0.542–2.190

0.809

1.394

0.482–4.034

0.540

Pathologic cervical tumor size^*

≥40 vs. < 40 mm

1.639

0.816–3.295

0.165

1.834

0.899–3.741

0.095

1.544

0.517–4.612

0.437

1.557

0.518–4.679

0.431

Indication for CCRT

High-risk vs. Low-risk

2.613

1.014–6.736

0.047

2.741

1.032–7.283

0.043

5.504

0.720–42.091

0.100

4.316

0.547–34.044

0.165

Surgical approach

MIS vs. Open surgery

1.667

0.859–3.239

0.131

2.178

1.079–4.397

0.030

0.798

0.247–2.580

0.706

1.132

0.333–3.850

0.842

Additional chemotherapy

Yes vs. No

1.240

0.624–2.461

0.539

1.149

0.552–2.391

0.710

2.270

0.782–6.584

0.131

1.877

0.621–5.673

0.264